Thesis (Ph. D.)--University of Alabama at Birmingham, 2007. / Title from first page of PDF file (viewed Oct. 13, 2008). Includes bibliographical references.

Thesis (Ph. D.)--West Virginia University, 2002. / Title from document title page. Document formatted into pages; contains vii, 218 p. : ill. (some col.). Vita. Includes abstract. Includes bibliographical references.

Thèse (M.Sc.)--Université Laval, 2009. / Bibliogr.: f. 123-143. Publié aussi en version électronique dans la Collection Mémoires et thèses électroniques.

Thèse (M.Sc.)--Université Laval, 2007. / Bibliogr.: f. 66-70. Publié aussi en version électronique dans la Collection Mémoires et thèses électroniques.

Dissertation (Ph.D.)--The University of North Carolina at Greensboro, 2009. / Directed by Keith Erikson; submitted to the Dept. of Nutrition. Title from PDF t.p. (viewed Apr. 29, 2010). Includes bibliographical references (p. 154-191).

Thesis (Ph. D.)--Case Western Reserve University, 2006. / [School of Medicine] Department of Pharmacology. Includes bibliographical references. Available online via OhioLINK's ETD Center.

Thesis (Ph. D.) University of Missouri-Columbia, 2006. / The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from title screen of research.pdf file (viewed on August 9, 2007) Vita. Includes bibliographical references.

Thesis (Ph. D.)--University of California, San Diego, 2001. / Vita. Includes bibliographical references (leaves 122-132).

Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciencias Biologicas / Made available in DSpace on 2012-10-17T09:45:44Z (GMT). No. of bitstreams: 0Bitstream added on 2016-01-09T01:08:59Z : No. of bitstreams: 1 149228.pdf: 2011337 bytes, checksum: af54d03742f9ae8eb7d443c2580dfe7f (MD5) / Análise da influência do receptor GABAB no desenvolvimento da tolerância rápida ao etanol em camundongos, no teste do rota-rod. Os animais foram treinados diariamente, durante cinco dias, no aparelho do rota-rod, até que atingissem linha de base mínima para serem selecionados para os testes. No dia dos testes, a velocidade de queda (rpm/min) do animal, do eixo giratório do aparelho, foi registrada antes da administração de drogas, e comparada àquela registrada durante os experimentos. Foram estudados os efeitos do tratamento prévio com três drogas: o (-baclofeno, agonista GABAB; o CGP36742 e o CGP56433, antagonistas GABAB. O (-)baclofeno impediu o desenvolvimento da tolerância rápida de forma dependente da dose, mas os resultados com doses mais elevadas foram prejudicados pelos efeitos miorrelaxantes da droga. Tanto o CGP36742 quanto o CGP56433 facilitaram o desenvolvimento da tolerância rápida de forma dose-dependente. No entanto, a administração posterior de (-) baclofeno impediu total ou parcialmente essa facilitação pelo CGP36742, e não impediu os efeitos do CGP56433 na maioria das doses testadas. Finalmente, uma possível interação farmacocinética, entre as drogas utilizadas no estudo e o etanoi foi excluída através da dosagem da alcoolemia, que não revelou diferenças estatisticamente significantes entre as amostras encaminhadas para análise. Em conclusão, os resultados desse estudo sugerem o envolvimento do receptor GABAB no desenvolvimento da tolerância rápida aos efeitos do etanol. Sugere-se que este desenvolvimento tenha ocorrido, possivelmente, através da menor ou maior modulação do complexo NMDA, levando à inibição ou à facilitação de mecanismos ligados aos processos de aprendizagem e memória. receptor GABAB tolerância etanol (-)baclofeno CGP36742 CGP56433 NMDA aprendizagem memória.

Magnetic resonance spectroscopy (MRS) allows the non-invasive measurement of selected biological compounds in vivo. Despite MRS proven potential it is not yet a routine clinical tool operated by clinicians. This is mainly due to the complex procedure of MRS acquisition, lack of standardisation in both acquisition and analysis protocols along with lack of a standard quality control. This thesis intended to address these issues with the focus on four metabolites glutathione, glutamate, glutamine and GABA using MEGA-PRESS pulse sequence. Recommendations on acquisition and spectra analysis is made for the MRS protocol MEGA-PRESS aiming to detect glutathione in vivo. This is based on an investigation of glutathione acquisition in vivo and in vitro and was aimed to answer the question: can glutathione be measured reliably using conventional pulse sequence PRESS or does it require editing? The results showed strong evidence of using editing in order to have a reliable glutathione concentration measurement. An analysis along with a quality control method is also presented to enable the extraction of glutamate and glutamine from a GABA-optimised MEGA-PRESS pulse sequence. This enables simultaneous measurements of GABA, glutamate and glutamine in a single acquisition. A criterion of NAA linewidth < 8 Hz and Glx CRLB < 16% were defined as optimum features in the GABA-edited spectrum for a reliable glutamate and glutamine quantification. Finally, due to the increasing interest in functional MRS of GABA using MEGAPRESS an investigation on the feasibility of measuring GABA in a functional-MRS setting was performed with recommendations on study designs and subject size. Power calculations suggest that detecting a 40% change in GABA using a 4'30" acquisition requires 9-93 subjects per group in a between-group study design and 13- 68 participants in a within-session design, depending on the region of interest. This thesis is set out in the Journal format thesis. Three introductory chapters, with each experimental study presented as a chapter and a final chapter that summarizes and discusses the work. Results in this thesis provide a basis for a standard and reliable MRS pipeline to reliably measure glutathione, glutamate, glutamine and GABA using MEGA-PRESS pulse sequence at 3 Tesla.